Browse by Author

Article

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reed, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L. (2015) The Immunosuppressive Ligands PD-L1 and CD200 are Linked in AML T-cell Immunosuppression: Identification of a New Immunotherapeutic Synapse. Leukemia, 29 (9). pp. 1952-1954. ISSN Print: 0887-6924 Online: 1476-5551

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Hills, R.K., Wang, E.C.Y., Burnett, A.K., Man, S., Darley, R.L. and Tonks, A. (2012) Expression of CD200 on AML Blasts Directly Suppresses Memory T-cell Function. Leukemia, 26 (9). pp. 2148-2151. ISSN Print: 0887-6924 Online: 1476-5551

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Hills, R.K., Wang, E.C.Y., Burnett, A.K., Man, S., Darley, R.L. and Tonks, A. (2012) Increased CD200 Expression in Acute Myeloid Leukemia is Linked With an Increased Frequency of FoxP3+ Regulatory T Cells. Leukemia, 26 (9). pp. 2146-2148. ISSN Print: 0887-6924 Online: 1476-5551

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Wang, E.C.Y., Man, S., Hills, R.K., Burnett, A.K., Tonks, A. and Darley, R.L. (2011) CD200 Expression Suppresses Natural Killer Cell Function and Directly Inhibits Patient Anti-tumor Response in Acute Myeloid Leukemia. Leukemia, 25 (5). pp. 792-799. ISSN Print: 0887-6924 Online: 1476-5551

Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S. and Burnett, A.K. (2011) The Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Myeloid Leukemia Cells and Acts in Synergy with Cytarabine. Haematologica, 96 (3). pp. 393-399. ISSN Print: 0390-6078 Online: 1592-8721

Conference or Workshop Item

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reid, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L. (2014) CD200 and PD1-L1 in AML Are Associated with Expanded PD-1+ Late Differentiated CD8+ T Cells and a Decreased CD4:CD8 Ratio: a New Link Between Distinct Immunosuppressive Pathways. In: 56th American Society of Hematology Annual Meeting and Exposition, 6th - 9th December 2014, San Francisco. (Unpublished)

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Man, S., Hills, R.K., Wang, E.C.Y., Burnett, A.K., Darley, R.L. and Tonks, A. (2011) CD200 Inhibits Memory Th1 Cell Function in Acute Myeloid Leukaemia (AML). In: Annual Congress of the British Society for Immunology, 5th - 8th December 2011, Liverpool, UK. (Unpublished)

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Man, S., Hills, R., Wang, E.C.Y., Burnett, A.K., Darley, R.L. and Tonks, A. (2010) Over-expression of CD200 in Acute Myeloid Leukemia Mediates the Expansion of Regulatory T-lymphocytes and Directly Inhibits Natural Killer Cell Tumor Immunity. In: 52nd American Society of Hematology Annual Meeting and Exposition, 4th - 7th December 2010, Orlando, Florida.

Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S., Pepper, C. and Burnett, A.K. (2009) Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukaemia Cells and Acts in Synergy with Cytarabine. In: 51st American Society of Hematology (ASH) Annual Meeting and Exposition, 5th - 8th December 2009, New Orleans, LA, USA. (Unpublished)

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Man, S., Wang, E., Burnett, A.K., Darley, R.L. and Tonks, A. (2009) The role of CD200 in AML tumour immunity. In: RUNX Transcription Factors in Development and Disease Annual Meeting, 16-19 August, 2009, Oxford. (Unpublished)